OR WAIT 15 SECS
Rita C. Peters is editorial director of BioPharm International, Pharmaceutical Technology, and Pharmaceutical Technology Europe.
By adapting techniques from other sciences-and exploring better tools for biologics drug development-researchers are addressing challenges of protein characterization.
Proteins must be characterized at many phases of biopharmaceutical research, development, and manufacturing, each with differing demands and requirements. Instrument capabilities-and limitations-influence the speed and success of development efforts. Researchers from biopharma, contract service organizations, and academia face challenges of selecting and optimizing appropriate techniques for protein characterization needs.
Experts interviewed by BioPharm International shared similar concerns about the need to conduct complex protein characterization studies under the pressures of tight timelines and urgency to get new drug products to clinic and approval.
eBook: Biopharma Laboratory Best Practices 2018
When referring to this article, please cite it as R. Peters, "Complex Protein Studies Demand Dynamic Techniques," BioPharm International Biopharma Laboratory Best Practices eBook (October 2018).
Related Content:Analytical Instrumentation | Analytical Methods | Biopharmaceutical Analysis | Biopharmaceutical Analysis: Mass Spectrometry | Biopharmaceutical Analysis: ICP-MS | Biopharmaceutical Analysis: NMR | Biopharmaceutical Analysis: Raman | Biopharmaceutical Analysis: LC-MS | Biopharmaceutical Analysis: HPLC/UHPLC